Longview News-Journal

Boehringer Ingelheim launches VETMEDIN® Solution (pimobendan oral solution), first oral solution approved by the FDA for congestive heart failure in dogs

DULUTH, Ga, Nov. 22, 2024 /PRNewswire/ -- Boehringer Ingelheim, a global leader in animal health, launched VETMEDIN ® Solution, the first oral solution approved by the U.S. Food and Drug ...
dvm360

Drug for delaying congestive heart failure in dogs is approved by the FDA

Officials for the FDA have expanded its’ approval of pimobendan chewable tablets (Vetmedin; Boehringer Ingelheim) to include ...
WPTV-TV

COVID-19 pandemic contributing to shortage in medication for pets with heart problems

VERO BEACH, Fla. — COVID-19 is proving to take a toll on some pets, as a potentially life-saving medication for dogs with heart problems is in short supply because of production issues tied to the ...
MarketWatch

Boehringer Ingelheim launches VETMEDIN(R) Solution (pimobendan oral solution), first oral solution approved by the FDA for congestive heart failure in dogs

-- Heart disease in dogs is almost as common as it is in humans, affecting approximately 10 percent of dogs in their lifetime1 -- Previous studies have shown that VETMEDIN(R) could help improve the ...